Found 6 matching trials
A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC
PHASE2The purpose of this study is to improve disease control and survival for pa...
Location
Yale University School Of Medicine
A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
PHASE1The purpose of this clinical research is to assess the safety and tolerabil...
Location
Roswell Park Cancer Institute
A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors
PHASE1The purpose of this research study is to determine the highest dose of the ...
Location
Indiana University Med Center
Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer
PHASE2This is an open label, monocentric, uncontrolled phase II trial with Dacomi...
Location
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer
PHASE1Lung cancer tumors become resistant to the first generation epidermal growt...
Location
Clinical Trials Office University of Colorado Hospital (CTO)
BMS-599626 in Patients With Advanced Solid Malignancies
PHASE1The purpose of this trial is to identify the highest oral dose of BMS-59962...
Location
Local Institution